“Discover NutraShure’s BIOMEnd: A Fresh Addition to Gut Health Supplements”

NutraShure Distribution, LLC, a top-tier supplier and distributor of premium ingredients, has revealed that its pioneering ingredient, BIOMEnd, is now a part of two health supplements: Silver Fern’s Postbiotic+ and Beneve’s Xcelerate G3. BIOMEnd, a groundbreaking form of the fatty acid butyrate, is currently patent-pending.

Butyrate — a four-carbon, short-chain fatty acid — is inherent in specific foods and is also synthesized by the gut flora during the breakdown of dietary fiber.

Since its launch in May 2024, BIOMEnd has been delivered by formulating it as L-lysine butyrate. This transformation makes the ingredient tasteless, easy to dissolve, and simple to incorporate in an array of supplement types, including powders, capsules, gummies, among others. According to the company, the form of BIOMEnd assures uniform dispersion and spread in a liquid medium due to its complete solubility.

Silver Fern’s Postbiotic+ uses BIOMEnd to form an innovative gut health regimen, holding the potential to promote complete health. This supplement aims to enhance gut health by tending to both the structural and immune functionalities of a person’s GI system. Similarly, Beneve’s Xcelerate G3, which also incorporates BIOMEnd, presents a rounded approach to gut upkeep and weight management, incorporating a unique mix of ingredients.

NutraShure’s CEO and founder, Brandon Sojka, stated that BIOMEnd is revolutionizing the application of butyrate in the market, paving the path for previously unexplored delivery forms. Sojka cited Postbiotic+ and Xcelerate G3 as instances of how brands use BIOMEnd to devise inventive recipes. He anticipates further cooperation with their partners in 2025 to explore new usages and delivery forms that continue to push the boundaries of what is achievable with butyrate.